Normal blah blah blah response to mundane ASX question in relation to short term survival but the following paragraph sums up the response.
"As stated in the prospectus for the rights issue disclosed to the market on 28 November 2018 (the Prospectus), the Company’s capital requirements will be partly determined by a divestiture of the Infusion business, or if that does not eventuate, a further capital raising."
Ann: Response to ASX Appendix 4C Query, page-2
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $10.73 | $10.73 | $10.15 | $109.7K | 10.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490 | $10.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 911 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |